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Abstract The neurotoxin sensitivity of regulated exocytosis in
the pancreatic acinar cell was investigated using streptolysin-O
permeabilized pancreatic acini. Treatment of permeabilized acini
with botulinum toxin B (BoNT/B) or botulinum toxin D
(BoNT/D) had no detectable effect on Ca2+-dependent amylase
secretion but did result in the complete cleavage of VAMP 2. In
comparison, tetanus toxin (TeTx) treatment both significantly
inhibited Ca2+-dependent amylase secretion and cleaved VAMP
2. These results indicate that regulated exocytosis in the
pancreatic acinar cell requires a tetanus toxin sensitive protein(s)
other than VAMP 2. ß 2000 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The SNARE (SNAP receptor) complex mediates exocytosis
[1^3]. The complex consists of integral membrane proteins
resident in both the vesicle membrane (v-SNAREs) and the
plasma membrane (t-SNAREs), in addition to soluble cyto-
solic proteins including NSF (N-ethylmalemide sensitive fac-
tor) and K-SNAP (K-soluble NSF attachment protein) [1^3].
Numerous SNARE proteins have been identi¢ed, however,
only a limited number of these appear to be required for
regulated exocytosis. The predominant exocytotic v-SNARE
is VAMP 2 (vesicle associated membrane protein) [1,2]. Exo-
cytotic t-SNAREs include syntaxins 1, 2, 3 and 4, SNAP-25
(synaptosomal associated protein) and SNAP-23 [1^7].
The majority of the SNARE proteins are targets for clos-
tridial neurotoxins, including tetanus toxin (TeTx) and the
seven serotypes of botulinum toxin (BoNT/A^G) [8,9]. The
toxins are heterodimers consisting of a heavy chain that me-
diates cell association and internalization, and a light chain
that is a zinc metalloprotease with unique substrate speci¢city
[8,9]. The light chain is only active after it is released from the
heavy chain following internalization into the host cell. Cel-
lular substrates for the toxins include VAMP 2 (TeTx, BoNT/
B, BoNT/D), syntaxins 2, 3 and 4 (BoNT/C1) and SNAP-25
(BoNT/A and BoNT/E). Because of this unique characteristic
the clostridial neurotoxins have been very e¡ective tools for
de¢ning the roles of speci¢c SNARE proteins in regulated
exocytosis.
Several SNARE proteins have been identi¢ed in pancreatic
acinar cells [10^12]. Of these, only VAMP 2 (zymogen gran-
ule), syntaxin 2 (apical plasma membrane) and syntaxin 3
(zymogen granule) are associated with organelles involved in
regulated exocytosis and are thought to function in exocytosis
[10,11]. The involvement of VAMP 2 in exocytosis in pancre-
atic acinar cells has been investigated using tetanus toxin [10].
Toxin treatment of streptolysin-O (SLO) permeabilized acini
cleaved VAMP 2 and signi¢cantly inhibited Ca2-dependent
secretion suggesting that VAMP 2 is required for exocytosis in
the acinar cell [10]. Here we report that BoNT/B and BoNT/D
cleaved VAMP 2 but did not in£uence Ca2-dependent amy-
lase secretion from SLO permeabilized pancreatic acini. In
comparison, TeTx both cleaved VAMP 2 and signi¢cantly
inhibited amylase secretion. These ¢ndings indicate that a
tetanus toxin sensitive protein other than VAMP 2 is required
for regulated exocytosis in the pancreatic acinar cell.
2. Materials and methods
Collagenase (CLSPA) was purchased from Worthington Biochem-
icals, Freehold, NJ, USA. The neurotoxins were obtained from Cal-
biochem, La Jolla, CA, USA. All other biochemicals were acquired
from Sigma Chemical Co., St. Louis, MO, USA. The anti-VAMP 2
monoclonal antibody (Cl 69.1) [13] and anti-cellubrevin antibody were
generously donated by Dr. R. Jahn (Yale University) and Dr. P.
DeCamilli (Yale University), respectively.
2.1. Isolation of rat pancreatic acini
Rat pancreatic acini were prepared by collagenase digestion of pan-
creatic tissue slices according to the procedure we have previously
described [14,15].
2.2. Secretion assay
10 ml of the ¢nal acinar suspension was centrifuged at 300Ug for
5 min and the resulting acinar pellet resuspended in ice cold perme-
abilization bu¡er (139 mM K-glutamate, 20 mM PIPES, pH 6.6). This
process was repeated three times to remove all traces of the Krebs
Ringer bu¡er used to prepare the acini. Streptolysin-O was added to
the acini (0.5 IU/ml) and the suspension incubated on ice for 5 min.
This allows the SLO to bind to the acinar cell plasma membrane,
e⁄cient permeabilization of the acinar cells is obtained when the acini
are warmed above room temperature. The excess unbound SLO was
then removed from the acinar suspension by repeated sedimentation
and resuspension in fresh permeabilization bu¡er. The acinar suspen-
sion was divided into two 5 ml aliquots to which were added 5 ml of
priming bu¡er (139 mM K-glutamate, 20 mM PIPES pH 6.6, 4 mM
ATP, 0.4 mM EGTA, 8 mM MgCl2 and 2 mg/ml rat brain cytosol)
with or without a designated concentration of neurotoxin. Immedi-
ately before use, BoNTs and TeTx were incubated with 5 mM dithio-
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threitol for 1 h at 22‡C to reduce the interchain disulphide bonds and
activate the toxins. The two acinar suspensions were incubated, with
or without the neurotoxin, at 37‡C. After 30 min the acinar suspen-
sions were divided into 200 Wl aliquots to which were added an equal
volume of stimulation bu¡er (139 mM K-glutamate, 20 mM PIPES
pH 6.6, 7.6 mM EGTA, 2 mM ATP, 4 mM MgCl2, and su⁄cient
CaCl2 to give the desired concentration of free Ca2). The acini were
then incubated for a further 30 min at 37‡C. The aliquots of acini not
used for the secretion studies were immediately pooled, spun down,
lysed and prepared for Western blot analysis. The secretion incuba-
tions were stopped by placing the experimental tubes in an ice bath
for 5 min after which the acini were pelleted by centrifugation in an
Eppendorf microfuge (2000Ug for 2 min), and the supernatant re-
moved. The supernatant and the lysed acinar pellet were then assayed
for amylase as described in [16]. The secretory response was calculated
as the % of total cellular amylase secreted.
2.3. Western blot analysis
Sodium dodecyl sulphate^polyacrylamide gel electrophoresis (SDS^
PAGE) was performed according to the procedure of Laemmli [17].
For Western blotting, acinar cell lysates (10 Wg total protein per lane)
were separated on 12% SDS^PAGE gels and electrophoretically trans-
ferred onto PVDF membranes, which were then incubated with anti-
VAMP 2 primary antibodies. The bound primary antibodies were
then detected using a horseradish peroxidase conjugated secondary
antibody in conjunction with the ECL detection system (Amersham
Pharmacia Biotech). Typically exposure times for the blots were
1^2 min.
3. Results and discussion
To examine if VAMP 2 is required for regulated exocytosis
in the pancreatic acinar cell, I determined the in£uence of
BoNT/B (Fig. 1A) and BoNT/D (Fig. 2A) on Ca2-dependent
amylase secretion from SLO permeabilized pancreatic acini.
The majority of the cleavage sites for the neurotoxins in
SNARE proteins, including VAMP 2, lie within domains
that are involved in the protein^protein interactions that
form and stabilize the SNARE complex [18]. This means
that SNARE proteins present in SNARE complexes are resis-
tant to toxin proteolysis [19,20]. The problem of toxin acces-
sibility has been overcome by employing incubation condi-
tions that actively promote the ATP-dependent priming of
the exocytotic machine [21]. During priming there is an
NSF-catalyzed rearrangement of the SNARE complex that
renders the SNARE proteins susceptible to toxin proteolysis.
Taking the above observation into consideration the permea-
bilized acini were incubated with BoNT/B and D in the pres-
ence of 2 mM ATP and 1 mg/ml rat brain cytosol, conditions
known to promote the priming of exocytosis in the acinar cell
(P. Pad¢eld, unpublished observation). Neither BoNT (100
nM) had any detectable e¡ect on Ca2-dependent amylase
secretion from the SLO permeabilized acini.
As controls to check that toxin treatment did result in the
proteolysis of VAMP 2, aliquots of untreated and toxin
Fig. 1. Treating SLO permeabilized pancreatic acini with BoNT/B
has no e¡ect on Ca2-dependent amylase secretion but does result
in the cleavage of VAMP 2. Pancreatic acini were permeabilized
with SLO and then incubated with or without 100 nM BoNT/B for
30 min in the presence of 2 mM ATP and 1 mg/ml rat brain cyto-
sol. A: Aliquots of untreated and toxin treated acini were removed
and secretion stimulated by addition of Ca2. After 30 min the in-
cubations were terminated and the amount of amylase secreted de-
termined. The data are the means þ S.E.M. from three separate ex-
periments conducted on acini isolated from three di¡erent rats.
B: The remaining untreated and toxin treated acini were lysed and
10 Wg (total protein) samples analyzed for VAMP 2 by Western
blot analysis. The blot shown is representative of the Western blots
obtained from the three experiments conducted.
Fig. 2. Treating SLO permeabilized pancreatic acini with BoNT/D
has no e¡ect on Ca2-dependent amylase secretion but does result
in the cleavage of VAMP 2. Pancreatic acini were permeabilized
with SLO and then incubated with or without 100 nM BoNT/D for
30 min in the presence of 2 mM ATP and 1 mg/ml rat brain cyto-
sol. A: Aliquots of untreated and toxin treated acini were removed
and secretion stimulated by addition of Ca2. After 30 min the in-
cubations were terminated and the amount of amylase secreted de-
termined. The data are the means þ S.E.M. from three separate ex-
periments conducted on acini isolated from three di¡erent rats.
B: The remaining untreated and toxin treated acini were lysed and
10 Wg (total protein) samples analyzed for VAMP 2 by Western
blot analysis. The blot shown is representative of the three experi-
ments conducted.
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treated acini were removed, lysed and analyzed by Western
blot for VAMP 2 (Figs. 1B and 2B). No VAMP 2 band was
observed in the samples obtained from the toxin treated acini
suggesting that BoNT treatment had cleaved all the VAMP 2
present in the acini. To eliminate the possibility that a small
residual pool of VAMP 2 which was below the threshold of
detection using standard blotting conditions (see Section 2)
was present in the toxin treated acini, I increased sample
loading (up to 50 Wg protein per lane) and/or extended the
exposure times of the blots (up to 60 min). Even using these
modi¢ed conditions no VAMP 2 band was observed in the gel
lanes loaded with samples prepared from the BoNT toxin
treated acini (data not shown). Thus it must be assumed
that BoNT treatment did result in the complete elimination
of VAMP 2 from the permeabilized acini. This observation
plus the fact that neither BoNTs have any detectable in£uence
on Ca2-dependent amylase secretion indicates that VAMP 2
is not required for regulated exocytosis in the pancreatic aci-
nar cell.
Next I determined how treating permeabilized acini with
TeTx in£uenced Ca2-dependent amylase secretion (Fig. 3A)
and VAMP 2 concentration (Fig. 3B). Previous studies have
demonstrated that TeTx both signi¢cantly inhibits amylase
secretion and cleaves VAMP 2 in SLO permeabilized acini.
50 to 100 nM TeTx produced a maximal, 75^80%, inhibition
of Ca2-dependent amylase secretion. This level of inhibition
is two to three times higher than previously observed in SLO
permeabilized acini [10]. This disparity probably re£ects the
di¡erence in incubation conditions and times used. In partic-
ular, in the present study ATP and cytosol were included in
the toxin incubation bu¡er to promote the priming of exocy-
tosis and so optimize SNARE availability. Most recently, the
involvement of VAMP 2 in exocytosis in the acinar cell was
explored using an in vitro assay that monitors the fusion of
isolated zymogen granules with puri¢ed acinar cell plasma
membranes [4]. In this study, TeTx cleaved VAMP 2 but
only produced a small reduction in granule/plasma membrane
fusion. However, how accurately the in vitro fusion assay
reconstitutes Ca2-dependent exocytosis is unclear. In addi-
tion to inhibiting amylase secretion, 100 nM TeTx also
cleaved all the VAMP 2 present in the acini. In the light of
these ¢ndings and the results of the BoNT studies, it appears
that a TeTx sensitive protein other than VAMP 2 is required
for Ca2-dependent exocytosis in the pancreatic acinar cell.
Given that TeTx and BoNT/B cleave the same peptide bond
(Gln^Phe) it might appear surprising that BoNT/B did not
have the same e¡ect as TeTx and inhibit secretion. Detailed
examination of the enzymological properties of the two toxins
indicates that TeTx and BoNT/B interact di¡erently with their
substrates [22], therefore it is likely that under a speci¢c set of
conditions there is a unique set of substrates for each toxin.
Over the past 2 to 3 years numerous SNARE proteins, both
v-SNAREs and t-SNAREs, have been identi¢ed. The toxin
sensitivity of these proteins does vary, for example a TeTx
insensitive VAMP isoform has recently been identi¢ed in
Caco2 cells [23]. Thus it is possible, if not probable, that
VAMP 2 is not the sole TeTx sensitive protein expressed in
the pancreatic acinar cell. A BoNT/B insensitive protein im-
munologically related to VAMP 2 has been identi¢ed on the
zymogen granule membrane [24], however, this protein has
not been isolated or further characterized. It is therefore im-
possible to say whether this protein is the BoNT/B and BoNT/
D insensitive, but TeTx sensitive, factor required for exocyto-
sis in the acinar cell. In addition, a small quantity of cellu-
brevin (VAMP 3) is present in the granule membrane [25,26].
In neuroendocrine cells cellubrevin is cleaved by TeTx, BoNT/
B and BoNT/D, however, under the conditions used in this
study it is possible that the cellubrevin present in the acinar
cells is resistant to one or more of the toxins. We therefore
examined the in£uence of the three bacterial neurotoxins on
cellubrevin concentration in SLO permeabilized acini (Fig. 4).
All three neurotoxins (100 nM) cleaved the entire pool cellu-
brevin present in the permeabilized acini indicating that cellu-
brevin, like VAMP 2, does not appear to be required for
exocytosis in the acinar cell. It has been suggested that
Fig. 3. Treating SLO permeabilized pancreatic acini with TeTx in-
hibits Ca2-dependent amylase secretion and results in the cleavage
of VAMP 2. Pancreatic acini were permeabilized with SLO and
then incubated with increasing concentrations of TeTx for 30 min
in the presence of 2 mM ATP and 1 mg/ml rat brain cytosol. A:
Aliquots of treated acini were removed and amylase secretion stimu-
lated by addition of Ca2. After 30 min the incubations were termi-
nated and the amount of amylase secreted determined. The data are
the means þ S.E.M. from three separate experiments conducted on
acini isolated from three di¡erent rats. B: The remaining acini were
lysed and 10 Wg (total protein) samples analyzed for VAMP 2 by
Western blot analysis. The blot shown is representative of the three
experiments conducted.
Fig. 4. Treating SLO permeabilized pancreatic acini with TeTx,
BoNT/B or BoNT/D results in the cleavage of cellubrevin. Pancreat-
ic acini were permeabilized with SLO and then incubated with or
without 100 nM TeTx, BoNT/B or BoNT/D for 30 min in the pres-
ence of 2 mM ATP and 1 mg/ml rat brain cytosol. The untreated
and toxin treated acini were lysed and 30 Wg (total protein) samples
analyzed for cellubrevin by Western blot analysis. The blot shown is
representative of the three experiments conducted.
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TeTx inhibits neurotransmitter release by stimulation of trans-
glutaminase [27,28]. Although there is no evidence that trans-
glutaminase has any signi¢cant in£uence on exocytosis in exo-
crine cells, this study does highlight the possibility that TeTx
inhibits exocytosis in the acinar cell by in£uencing a protein
other than a VAMP isoform.
In summary, this study demonstrates that Ca2-dependent
exocytosis in SLO permeabilized acini is sensitive to TeTx but
not BoNT/B and D. In contrast, all three toxins cleaved
VAMP 2. The di¡erence in toxin sensitivities indicates that
a TeTx sensitive protein other than VAMP 2 is required for
exocytosis in the acinar cell. Currently studies are underway
to identify the TeTx sensitive protein.
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